טוען...
Tackling breast cancer chemoresistance with nano-formulated siRNA
Breast cancer is the leading cancer diagnosed in women and the second leading cause of cancer-related deaths in women. Current limitations to standard chemotherapy in the clinic are extensively researched, including problems arising from repeated treatments with the same drugs. The phenomenon that c...
שמור ב:
| הוצא לאור ב: | Gene Ther |
|---|---|
| Main Authors: | , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
2016
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5540231/ https://ncbi.nlm.nih.gov/pubmed/27648580 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/gt.2016.67 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|